Dabur Pharma launches new chemotherapy treatment
Dabur Pharma on Thursday launched its new nano technology based chemotherapy agent, Nanoxel, in the country.
NEW DELHI: Dabur Pharma on Thursday launched its new nano technology based chemotherapy agent, Nanoxel, in the country.
The agent is an improved form of widely used anti-cancer drug Paclitaxel and has been approved by Drugs Controller-General of India (DGCI).
The company would start the clinical trials for the product in the US and Europe and expects to launch it there in another 18-36 months.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.